Teva
Teva boss quits over Board struggles
October 31, 2013Medical Communications, Sales and Marketing Copaxone, Levin, Teva, generics
Teva’s president and chief executive Dr Jeremy Levin has unexpectedly quit as the firm struggles with staff cuts and management …
Teva to axe 5,000 jobs in savings drive
October 11, 2013Manufacturing and Production, Research and Development, Sales and Marketing Copaxone, FDA, Teva, cuts
The world’s largest generic drugmaker Teva will cut around 5,000 jobs from its global workforce as it looks to speed-up …
Teva in Cancer Research UK tie-up
September 20, 2013Medical Communications, Research and Development, Sales and Marketing CRUK, Cancer, R&D, Teva
FDA approves first generic Xeloda
September 17, 2013Sales and Marketing FDA, Roche, Teva, Xeolda, breast cancer, colorectal cancer
Teva and Lonza abandon biosimilars joint venture
July 26, 2013Manufacturing and Production, Research and Development CMO, Levin, Lonza, Teva, biosimilars
Escalating costs have led Teva and contract manufacturing organisation (CMO) Lonza to abandon a joint venture set up in 2009 …
No evidence of fault at Teva plant linked to drug switch death
June 14, 2013Manufacturing and Production Teva, death
France’s medicines regulator has concluded that a plant operated in the country by generic drugmaker Teva was not at fault …
Pfizer wins $2.15 billion patent case
June 13, 2013Sales and Marketing Pfizer, Takeda, Teva, protonix
Pfizer and Takeda are to split $2.15 billion in damages from two generics manufacturers as a settlement for lost sales, …
French regulator probes Teva plant after patient death
June 12, 2013Manufacturing and Production Teva, furosemide, zopiclone
France’s medicines regulator has started an investigation into a manufacturing facility operated by generic firm Teva in the wake of …
Fatality as blast rocks Teva manufacturing plant
May 31, 2013Manufacturing and Production Teva
One man died and more than 30 other people were injured after an explosion hit a manufacturing facility operated by …
Teva says US facility will close in cost-cutting drive
May 3, 2013Manufacturing and Production Teva, closure, cuts
Teva has said it will shut down a manufacturing and R&D facility in Pennsylvania by 2017, with the loss of …
Teva plans sale of troubled Irvine plant
February 11, 2013Manufacturing and Production FDA, Teva
Teva has decided to sell off an injectable pharmaceutical production plant in Irvine, California, that was shut down temporarily for …
Teva appoints Arie Belldegrun to Board of directors
February 11, 2013Manufacturing and Production, Research and Development, Sales and Marketing Arie Belldegrun, Teva
Teva Pharmaceuticals has announced that Dr Arie Belldegrun has been appointed by the directors of Teva to fill a vacancy …
Teva revamp will see manufacturing shake-up
December 17, 2012Manufacturing and Production Levin, Teva, manufacturing
Teva’s recent announcement of a major restructuring of its business to cut costs and maintain profitability includes a revamp of …
Hospira on track to return propofol to market
November 13, 2012Manufacturing and Production Ball, Hospira, Teva
Shortages of the short-acting anaesthetic propofol in the US could be helped by the return to market of a generic …
Leadership changes at Teva
November 8, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Levin, Teva
Teva Pharmaceutical has announced some management changes to its executive leadership team. Allan Oberman, senior vice president of North America …
Latest content
EnteroBiotix appoints former GSK Chief Medical Officer to board
AI: an early warning system for patient safety
Highlighting the value of lab research for healthcare innovation
